Gamma Irradiation-Inactivated Respiratory Syncytial Virus Vaccine Provides Protection but Exacerbates Pulmonary Inflammation by Switching from Prefusion to Postfusion F Protein

Gamma Irradiation-Inactivated Respiratory Syncytial Virus Vaccine Provides Protection but Exacerbates Pulmonary Inflammation by Switching from Prefusion to Postfusion F Protein

ABSTRACT Respiratory syncytial virus (RSV) is a common respiratory pathogen that causes lower respiratory diseases among infants and elderly people. Moreover, formalin-inactivated RSV (FI-RSV) vaccine induces serious enhanced respiratory disease (ERD). Radiation has been investigated as an alternati...

Full description

Bibliographic Details
Main Authors:	Fengjia Chen, Hae-Ran Park, Hyun Jung Ji, Yeongkag Kwon, Min-Kyu Kim, Joon Young Song, Ki Bum Ahn, Ho Seong Seo
Format:	Article
Language:	English
Published:	American Society for Microbiology 2023-08-01
Series:	Microbiology Spectrum
Subjects:	respiratory syncytial virus enhanced respiratory disease inactivated vaccine gamma irradiation inactivation prefusion F postfusion F
Online Access:	https://journals.asm.org/doi/10.1128/spectrum.01358-23

Similar Items

Virus-like particles containing a prefusion-stabilized F protein induce a balanced immune response and confer protection against respiratory syncytial virus infection in mice
by: Jin Luo, et al.
Published: (2022-12-01)

A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults
by: Antonios O. Aliprantis, et al.
Published: (2021-05-01)

Enhancing Anti-G Antibody Induction by a Live Single-Cycle Prefusion F—Expressing RSV Vaccine Improves In Vitro and In Vivo Efficacy
by: Pramila Lamichhane, et al.
Published: (2022-11-01)

Stabilisation of Viral Membrane Fusion Proteins in Prefusion Conformation by Structure-Based Design for Structure Determination and Vaccine Development
by: Henriette Ebel, et al.
Published: (2022-08-01)

The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis
by: Daisuke Kurai, et al.
Published: (2024-12-01)

Mucosal Application of a Low-Energy Electron Inactivated Respiratory Syncytial Virus Vaccine Shows Protective Efficacy in an Animal Model
by: Valentina Eberlein, et al.
Published: (2023-08-01)

The protective immunity induced by intranasally inoculated serotype 63 chimpanzee adenovirus vector expressing human respiratory syncytial virus prefusion fusion glycoprotein in BALB/c mice
by: Lei Huang, et al.
Published: (2022-11-01)

Detailed Evolutionary Analyses of the F Gene in the Respiratory Syncytial Virus Subgroup A
by: Mariko Saito, et al.
Published: (2021-12-01)

RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models
by: Freek Cox, et al.
Published: (2023-03-01)

Variation in Thermal Stability among Respiratory Syncytial Virus Clinical Isolates under Non-Freezing Conditions
by: Yuki Kitai, et al.
Published: (2022-03-01)

GENETIC AND ANTIGENIC CHARACTERISTICS OF RESPIRATORY SYNCYTIAL VIRUS STRAINS ISOLATED IN ST. PETERSBURG IN 2013-2016
by: V. Z. Krivitskaya, et al.
Published: (2017-12-01)

Efficient Inactivation of SARS-CoV-2 and Other RNA or DNA Viruses with Blue LED Light
by: Chiara Terrosi, et al.
Published: (2021-12-01)

Soluble F proteins exacerbate pulmonary histopathology after vaccination upon respiratory syncytial virus challenge but not when presented on virus-like particles
by: Youri Lee, et al.
Published: (2017-11-01)

Inactivation of Human Influenza Virus Using Gamma Irradiation
by: Ailar Sabbaghi, et al.
Published: (2019-09-01)

Association between Serum Hyponatremia and Severity of Respiratory Symptoms in Infants with Respiratory Syncytial Virus Infection
by: Sun Oh Yum, et al.
Published: (2020-05-01)

Molecular Evolution of Respiratory Syncytial Virus Fusion Gene, Canada, 2006–2010
by: Jesse Papenburg, et al.
Published: (2012-01-01)

Photodynamic inactivation of influenza virus as a potential alternative for the control of respiratory tract infections
by: Rafael T. Aroso, et al.
Published: (2021-09-01)

Resurgence of Respiratory Syncytial Virus in Children: An Out-of-Season Epidemic in Portugal
by: Ana Rita Torres, et al.
Published: (2023-01-01)

Comparison of indirect and direct immunofluorescence for the detection of Respiratory Syncytial Virus
by: Stefano Gambarino, et al.
Published: (2009-12-01)

A causal relationship between face-patch activity and face-detection behavior
by: Srivatsun Sadagopan, et al.
Published: (2017-04-01)

Sonophotodynamic Inactivation: The power of light and ultrasound in the battle against microorganisms
by: Fernanda Alves, et al.
Published: (2021-09-01)

Respiratory syncytial virus groups A and B in Porto Alegre, Brazil, from 1990 to 1995 and 1998
by: Straliotto Selir M, et al.
Published: (2001-01-01)

Clinical-epidemiological evaluation of respiratory syncytial virus infection in children attended in a public hospital in midwestern Brazil
by: Tatiany Calegari, et al.

Respiratory Syncytial Virus Reinfections in Children in Western Australia
by: David A. Foley, et al.
Published: (2023-12-01)

Addendum to Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level
by: Ian G. Barr, et al.
Published: (2022-03-01)

Voltage sensor inactivation in potassium channels
by: Robert eBähring, et al.
Published: (2012-05-01)

Contribution of Dendritic Cells in Protective Immunity against Respiratory Syncytial Virus Infection
by: Hi Eun Jung, et al.
Published: (2020-01-01)

Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity
by: Miguel Á. Muñoz-Alía, et al.
Published: (2024-02-01)

Clinical impact of respiratory syncytial virus infection on children hospitalized for pertussis
by: Ruimu Zhang, et al.
Published: (2021-02-01)

Residential crowding and severe respiratory syncytial virus disease among infants and young children: A systematic literature review
by: Colosia Ann D, et al.
Published: (2012-04-01)

RESPIRATORY SYNCYTIAL VIRUS INFECTION AMONG YOUNG CHILDREN WITH ACUTE RESPIRATORY INFECTION
by: M. Milani
Published: (2003-08-01)

RESPIRATORY SYNCYTIAL VIRUS INFECTION AMONG YOUNG CHILDREN WITH ACUTE RESPIRATORY INFECTION
by: M. Milani
Published: (2003-12-01)

Respiratory Syncytial Virus Vaccines for the Prevention of Lower Respiratory Tract Infections in Patients Living with Chronic Obstructive Pulmonary Disease: A Rapid Review
by: Paul M. Boylan, et al.
Published: (2024-01-01)

Development of a Novel Oral Vaccine Against Human Resipratory Syncytial Virus
by: Jalilian, Farid Azizi
Published: (2011)

A Regional Report: Respiratory Syncytial Virus Infection in 2016-17 Season
by: Erin Baroni, et al.
Published: (2018-01-01)

Antibody responses in mice after immunization with inactivated bovine respiratory syncytial virus using different adjuvants Respostas de anticorpos em camundongos após imunização com vírus respiratório sincicial bovino inativado utilizando diferentes adjuvantes
by: Fernando Rosado Spilki, et al.
Published: (2010-11-01)

Hospitalization in pregnancy due to human respiratory syncytial virus associated disease
by: Janelle Santos, et al.
Published: (2023-01-01)

Patient equity and respiratory syncytial virus Immunoprophylaxis
by: H. Cody Meissner
Published: (2019-01-01)

Neonatal Calf Infection with Respiratory Syncytial Virus: Drawing Parallels to the Disease in Human Infants
by: Timothy A. Reinhardt, et al.
Published: (2012-12-01)

Alveolar-like Macrophages Attenuate Respiratory Syncytial Virus Infection
by: Bárbara N. Porto, et al.
Published: (2021-09-01)